Detection of Intron22 Mutations in Iraqi Female Carriers in Wasit Province with Hemophilia A

Authors

  • Maysoon Mohammed Hassan

Keywords:

hemophilia A, factor 8 gene, carriers, intron 22 mutations

Abstract

The background: One of the prevalent main concerns in the medical world is the identification of#xA0; Intron22#xA0; mutations in the Factor VIII gene carried by Iraqi patient in Wasit#xA0;town, in Iraq#xA0;suffering Hemophilia A (#xA0;classical hemophilia)#xA0;which #xA0;is#xA0;related to a #xA0;X-hromosome#xA0;recessive#xA0;haemorrhage#xA0;afflictions as the result of a flaw in the#xA0;coagulation factor#xA0;VIII (FVIII). It is essentially#xA0;related with#xA0;F8 mutations#xA0;of#xA0;Intron22#xA0;inversion#xA0;which forms the most typical kind of#xA0;mutations of#xA0;blood afflictions#xA0;worldwide involving half#xA0;the patients suffering from severe#xA0;Hemophilia A that possesses mutations, in addition to Intron 1#xA0;inversion suffered by 5%#xA0;of severe#xA0;Hemophilia A patients.#xA0;All of the#xA0;inversion mutations are suffered mainly#xA0;by males, and uncommonly by females due to the#xA0;intrachromosomal recombination among the homologous areas, in#xA0;inversion 1#xA0;or#xA0;22, with extragenic copy#xA0;posited the#xA0;telomeric to the Factor VIII#xA0;gene.#xA0;#xA0;Unfortunately, there is an absence#xA0;in#xA0;Iraq#xA0;on researches pertaining#xA0;blood affliction gene#xA0;identification in persons who carries the Intron22 mutations#xA0;exception in#xA0;the current research. Aims of study: The objectives of the research is to to analyze through the detection mechanisms, the existence of#xA0;Intron 22#xA0;mutations in the#xA0;Factor VIII#xA0;gene#xA0;of 10#xA0;#xA0;Hemophilia A#xA0;Iraqi carriers cohort families. The hypothesis and anticipated result is that#xA0;there will be#xA0;a minimal margin of hazardous possibility for#xA0;the recurrence.#xA0;The hereditary F8 mutation#xA0;is#xA0;unknown#xA0;to be present on the maternal side of the patient#xA0;sufferer due to the possibilty#xA0;of germline#xA0;mosaics#xA0;that exists within the#xA0;community. Patients and Methods: The current research involved 10#xA0;Iraqi Hemophilia A carrier, and#xA0;5#xA0;healthy sampling to act as#xA0;the control.This study had utilized#xA0;medicine and science#xA0;school#xA0;labs, with the inclusion#xA0;of AL Karama Teaching Hospital over a time period from#xA0;November, 2016 up to#xA0;January, 2017. The aforementioned respective carriers#xA0;have a previous history of#xA0;diagnosed case history and DNA testing. Results:#xA0;During the whole of the screening duration for Inv22(intron#xA0;twenty two#xA0;inversions) amongst the#xA0;Hemophilia A carriers, the outcomes indicated that 4 out of the 10 carriers#xA0;(40%) suffer from these mutations. Discussion: The research findings highlights on the significance of the Inv22#xA0;analysis and their relationship with positive hereditary case history within the#xA0;#xA0;Hemophilia A carriers, in addition to our ongoing pursuit of seeking for#xA0; Inv1 mutations. Conclusions: The outcomes defines the detrimental influence#xA0;of a diagnosed positive#xA0;family case history and the proximal#xA0;affinity lineage in marriage. There is a dire necessity for Hemophilia A carriers to be given#xA0;specialized and dedicated#xA0;obstetrical#xA0;attention with#xA0;close#xA0;contact with the haemophilia centre, in addition the management#xA0;processes concerning the case should be available#xA0;ought and#xA0;identified. The outcome manifests the pathway towards a genetic guideline. Having the information pertaining the gender of the foetus gender#xA0;is significantly crucial to assist in the supervision of labor, in addition to#xA0;diagnostic processes.

How to Cite

Maysoon Mohammed Hassan. (2017). Detection of Intron22 Mutations in Iraqi Female Carriers in Wasit Province with Hemophilia A. Global Journal of Medical Research, 17(F1), 13–23. Retrieved from https://medicalresearchjournal.org/index.php/GJMR/article/view/1266

Detection of Intron22 Mutations in Iraqi Female Carriers in Wasit Province with Hemophilia A

Published

2017-01-15